期刊文献+

养肝益水颗粒对高血压病患者内皮功能的影响 被引量:9

Effect of Yangganyishui Granule on Endothelium Function of Hypertention Patients
暂未订购
导出
摘要 目的观察养肝益水对高血压病患者内皮功能的影响,并探讨其机理。方法患者120例,随机分为两组。治疗组在西医常规降压治疗的基础上给予养肝益水颗粒,对照组予西医常规降压,疗程4周。观察治疗前后两组血压、一氧化氮(NO)、内皮素(ET-1)、超敏C反应蛋白(hs-CRP)、尿微量白蛋白(MAU)等指标的变化情况。结果治疗后两组血压改善相近;治疗组NO、ET-1、hs-CRP、MAU的改善优于对照组。结论养肝益水颗粒可以改善高血压病患者内皮功能,这种作用独立于降压之外,可能与改善高血压病患者炎症因子、减少微量白蛋白排出有关。 Objective:To observe the effect of Yangganyishui Granule(YGYSG) on endothelium function of essential hypertention(EH) patients and to explore the mechanism of it.Methods:120 EH patients were divided into randomly the treatment group and the control group.Both 2 groups were treated with conventionally therapeutic methods of antihypertensive for 4 weeks.Simultaneously,the YGYSG was added into the treatment group.We observe the changes of nitrogen monoxidum(NO),endothelin 1(ET-1),high-sensitivity C-reactive protein(hs-CRP),microalbuminuria(MAU) and the blood pressure in 120 cases before and after therapy.Results:After therapy,the blood pressure in two groups were reduced evidently than before.Howeve,the deference of 2 groups was not obviously before and after therapy.NO was promoted after therapy in the control group,but the deference was not obvious than before.In the treatment group,NO were promoted evidently after therapy.NO were promoted evidently in the treatment group than in the control group after therapy.In the 2 group,hs-CRP and MAU were reduced evidently after therapy.Compared with the control group,the decrease of the treatment group was more obviously.ET-1 was reduced after therapy in the control group,but the deference was not obvious than before.In the treatment group,ET-1 was reduced evidently after therapy.ET-1 was reduced evidently in the treatment group than in the control group after therapy.Conclusion:YGYSG improves the endothelium function of the hypertention patients.The improvement is independent on the decrease of blood pressure.It possibly associate with improvement of inflammation gene and decrease of MAU in the hypertention patients.
出处 《中国中医急症》 2012年第2期182-184,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 安徽中医学院临床科研基金项目(2008lcky001)
关键词 养肝益水颗粒 高血压病 内皮功能 Yangganyishui Granule Essential hypertension Endothelium function
  • 相关文献

参考文献16

二级参考文献86

  • 1顾健霞.周氏养肝益水颗粒减轻原发性高血压早期肾损害的作用观察[J].中医药临床杂志,2005,17(4):373-374. 被引量:15
  • 2汪其存,余晓燕,许克莲.高血压患者278例临床分析[J].安徽医药,2006,10(8):597-598. 被引量:6
  • 3[1]Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002,39(2 Suppl 2) :S1~ 246.
  • 4[2]Parving HH, Mogensen CE,Jensen HA,et al.Increased urinary albumin-excretion rate in benign essential hypertension [J] .Lancet 1974, 1(7868):1190~2.
  • 5[3]Mogensen CE.Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes [J]. N Eng J Med, 1984,310(6): 356~60.
  • 6[4]Mogensen CE, Schmitz. The diabetic kidney: from hyerfitration and microalbuminura to end stage renal failure [J]. Med Clin North Am,1988, 72(6): 1465 ~ 92.
  • 7[5]Weir MR. Microalbuminuria in type 2 diabetes: an important, overlooked cardiovascular risk factor [J]. J Clin Hypertens, 2004,6 (3):134 ~ 41.
  • 8[6]Hillege HL, Fidler V, Diercks GF,et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J]. Circulation, 2002,106(14): 1777 ~ 82.
  • 9[7]Barzilay JI, Peterson D, et al.The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The Cardiovascular Health Study [J] . Am J Kidney Dis, 2004,44: 25 ~ 34.
  • 10[8]Atkins RC, Polkinghorne KR, et al. Prevalence of albuminuria in Australia: The Ausdiab kidney study [J] .Kidney Int, 2004, 66(Suppl 92) :S22 ~ 4.

共引文献165

同被引文献113

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部